AstraZeneca unveils plan for $1.5bn ADC plant in Singapore

cafead

Administrator
Staff member
  • cafead   May 20, 2024 at 11:02: AM
via AstraZeneca is backing up its considerable investment in antibody-drug conjugates (ADCs) for cancer with the construction of a $1.5 billion new facility in Singapore to manufacture them.

article source